Elevated Circulating Levels of Inflammatory Markers in Patients with Acute Coronary Syndrome

International Journal of Vascular Medicine

Volumn 2015, Issue , 2015, Pages

  Al Shahi, Hamad ^a   Shimada, Kazunori ^a   Miyauchi, Katsumi ^a   Yoshihara, Takuma ^a   Sai, Eiryu ^a   Shiozawa, Tomoyuki ^a   Naito, Ryo ^a   Aikawa, Tatsuro ^a   Ouchi, Shohei ^a   Kadoguchi, Tomoyasu ^a   Miyazaki, Tetsuro ^a   Daida, Hiroyuki ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 18 BINDING PROTEIN; INTERLEUKIN 23; INTERLEUKIN 23P19; INTERLEUKIN 27; INTERLEUKIN 33; INTERLEUKIN 37; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; BLOOD SAMPLING; CARDIAC PATIENT; CATHETERIZATION; CLINICAL ARTICLE; FEMALE; GLOMERULUS FILTRATION RATE; HEART CATHETERIZATION; HUMAN; IMMUNOASSAY; INFLAMMATION; MALE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84945282482     PISSN: 20902824     EISSN: 20902832     Source Type: Journal    
DOI: 10.1155/2015/805375     Document Type: Article

References (35)

1. L. J. Laslett, P. Alagona Jr., B. A. Clark III et al., "The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: A report fromthe american college of cardiology, " Journal of the American College of Cardiology, vol. 60, no. 25, pp. S1-S49, 2012.
2. J. Frostegard, "Immunity, atherosclerosis and cardiovascular disease, " BMC Medicine, vol. 11, article 117, 2013.
3. E. Braunwald, "Unstable angina: An etiologic approach to management, " Circulation, vol. 98, no. 21, pp. 2219-2222, 1998.
4. D. T. Price and J. Loscalzo, "Cellular adhesion molecules and atherogenesis, " The American Journal ofMedicine, vol. 107, no. 1, pp. 85-97, 1999.
5. B. Oppmann, R. Lesley, B. Blom et al., "Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12, " Immunity, vol. 13, no. 5, pp. 715-725, 2000.
6. S. Pflanz, J. C. Timans, J. Cheung et al., "IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naiveCD4+ Tcells, " Immunity, vol. 16, no. 6, pp.779-790, 2002.
7. S. Kamiya, T. Owaki, N. Morishima, F. Fukai, J. Mizuguchi, and T. Yoshimoto, "An indispensable role for STAT1 in IL-27-induced T-bet expression but not proliferation of naive CD4+ T cells, " The Journal of Immunology, vol. 173, no. 6, pp. 3871-3877, 2004.
8. H. Ait-Oufella, S. Taleb, Z. Mallat, and A. Tedgui, "Recent advances on the role of cytokines in atherosclerosis, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 5, pp. 969-979, 2011.
9. A.M. Miller, D. Xu, D.L. Asquithet al., "IL-33 reduces thedevelopment of atherosclerosis, " Journal of Experimental Medicine, vol. 205, no. 2, pp. 339-346, 2008.
10. M. F. Nold, C. A. Nold-Petry, J.A. Zepp, B. E. Palmer, P. Bufler, and C. A. Dinarello, "IL-37 is a fundamental inhibitor of innate immunity, " Nature Immunology, vol. 11, no. 11, pp. 1014-1022, 2010.
11. H. Yamashita, K. Shimada, E. Seki, H. Mokuno, and H. Daida, "Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris, " American Journal of Cardiology, vol. 91, no. 2, pp. 133-136, 2003.
12. T. Yoshihara, K. Shimada, K. Fukao et al., "Omega 3 polyunsaturated fatty acids suppress the development of aortic aneurysms through the inhibition of macrophage-mediated inflammation, " Circulation Journal, vol. 79, no. 7, pp. 1470-1478, 2015.
13. K. Shimada, "Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis, " Circulation Journal, vol. 73, no. 6, pp. 994-1001, 2009.
14. H. G. Rus, R. Vlaicu, and F. Niculescu, "Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall, " Atherosclerosis, vol. 127, no. 2, pp. 263-271, 1996.
15. C. P. J. Maury and A.-M. Teppo, "Circulating tumour necrosis factor-(cachectin) in myocardial infarction, " Journal of Internal Medicine, vol. 225, no. 5, pp. 333-336, 1989.
16. G. Liuzzo, A. Buffon, L.M. Biasucci et al., "Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina, " Circulation, vol. 98, no. 22, pp. 2370-2376, 1998.
17. C. S. R. Lankford and D. M. Frucht, "A unique role for IL-23 in promoting cellular immunity, " Journal of Leukocyte Biology, vol. 73, no. 1, pp. 49-56, 2003.
18. J. L. Langowski, X. Zhang, L. Wu et al., "IL-23 promotes tumour incidence and growth, " Nature, vol. 442, no. 7101, pp. 461-465, 2006.
19. E. D. T. Wojno, N. Hosken, J. S. Stumhofer et al., "A role for IL-27 in limiting T regulatory cell populations, " Journal of Immunology, vol. 187, no. 1, pp. 266-273, 2011.
20. X. Lu, D. Lu, U. Narayan, and V. V. Kakkar, "The role of Thelper cells in atherosclerosis, " Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 9, no. 1, pp. 25-41, 2011.
21. T. Owaki, M. Asakawa, F. Fukai, J. Mizuguchi, and T. Yoshimoto, "IL-27 induces Th1 differentiation via p38 MAPK/T-bet-And intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways, " Journal of Immunology, vol. 177, no. 11, pp. 7579-7587, 2006.
22. S. Kempe, P. Heinz, E. Kokai, O. Devergne, N. Marx, and T. Wirth, "Epstein-barr virus-induced gene-3 is expressed in human atheroma plaques, " American Journal of Pathology, vol. 175, no. 1, pp. 440-447, 2009.
23. A. Wasserman, J. Ben-Shoshan, M. Entin-Meer, S. Maysel-Auslender, H. Guzner-Gur, and G. Keren, "Interleukin-33 augments Treg cell levels: A flaw mechanism in atherosclerosis, " The Israel Medical Association Journal, vol. 14, no. 10, pp. 620-623, 2012.
24. P.W. Zhao, W. G. Jiang, L. Wang et al., "Plasma levels of IL-37 and correlation with TNF-, IL-17A, and disease activity during DMARD treatment of rheumatoid arthritis, " PLoS ONE, vol. 9, no. 5, Article IDe95346, 2014.
25. C. Li, P. Zhao, X. Sun, Y. Che, and Y. Jiang, "Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with guillain-barr syndrome, " Mediators of Inflammation, vol. 2013, Article ID 639712, 9 pages, 2013.
26. L. Song, F. Qiu, Y. Fan et al., "Glucocorticoid regulates interleukin-37 in systemic lupus erythematosus, " Journal of Clinical Immunology, vol. 33, no. 1, pp. 111-117, 2013.
27. I. Anguera, F. Miranda-Guardiola, X. Bosch et al., "Elevation of serum levels of the anti-inflammatory cytokine interleukin-10 and decreased risk of coronary events in patients with unstable angina, " American Heart Journal, vol. 144, no. 5, pp. 811-817, 2002.
28. C. Heeschen, S. Dimmeler, C. W. Hamm et al., "Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes, " Circulation, vol. 107, no. 16, pp. 2109-2114, 2003.
29. K. Mizia-Stec, Z. Gaior, B. Zahorska-Markiewicz et al., "Serum tumour necrosis factoralpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes, " Coronary Artery Disease, vol. 14, no. 6, pp. 431-438, 2003.
30. G. Liuzzo, L.M. Biasucci, J. R. Gallimore et al., "The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina, " The New England Journal of Medicine, vol. 331, no. 7, pp. 417-424, 1994.
31. R. Deo, A. Khera, D. K. McGuire et al., "Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis, " Journal of theAmericanCollege of Cardiology, vol. 44, no. 9, pp. 1812-1818, 2004.
32. C. Herder, J. Baumert, B. Thorand et al., "Chemokines and incident coronary heart disease: results from the MONICA/KORA Augsburg case-cohort study, 1984-2002, " Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 9, pp. 2147-2152, 2006.
33. Z. Mallat, A. Corbaz, A. Scoazec et al., "Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability, " Circulation, vol. 104, no. 14, pp. 1598-1603, 2001.
34. N. K. Banda, A. Vondracek, D. Kraus et al., "Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein, " Journal of Immunology, vol. 170, no. 4, pp. 2100-2105, 2003.
35. P. Bufler, T. Azam, F. Gamboni-Robertson et al., "A complex of the IL-1 homologue IL-1F7b and IL-18-binding protein reduces IL-18 activity, " Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13723-13728, 2002.